Asapiprant

• Catalog Number: orb525729
• Category: Small Molecules
• Description: Asapiprant (BGE-175) is a potent and specific antagonist of human PGD2/PTGDR signaling with Ki of 0.44 nM. BGE-175 is currently in a Phase 2 clinical trial to test whether it can prevent disease progression and mortality in older patients hospitalized wit
• CAS Number: [932372-01-5]
• MW: 501.5521
• SMILES: S(C1C([H])=C([H])C(=C([H])C=1[H])OC([H])(C([H])([H])[H])C([H])([H])[H])(N1C([H])([H])C([H])([H])N(C2C([H])=C([H])C(C3=NC([H])=C([H])O3)=C(C=2[H])OC([H])([H])C(=O)O[H])C([H])([H])C1([H])[H])(=O)=O
• Formula: C₂₄H₂₇N₃O₇S
• Note: For research use only
• Expiration Date: 12 months from date of receipt.